Medicare人群中内皮角膜移植术后重复角膜移植的风险因素
基于2010-2019年Medicare索赔数据的回顾性队列研究,纳入94,829例内皮角膜移植术(EK),分析重复角膜移植的长期发生率及风险因素。重复角膜移植的总体概率在6个月、1年、5年和8年分别为6.1%、7.6%、14.3%和16.9%,黑人、亚洲人、合并青光眼、既往或同期青光眼手术及低手术量术者与风险增加相关。
要点
- EK术后重复角膜移植8年累积概率为16.9%,既往移植失败者最高达29.9%。
- 合并青光眼、既往或同期青光眼手术显著增加重复角膜移植风险。
- 黑人、亚洲人种及低手术量术者与重复角膜移植风险增加相关。
核心结论
- 黑人、亚洲人、合并青光眼、同期或既往青光眼手术及低手术量术者与重复角膜移植风险增加相关。
- 研究中发现的种族差异值得进一步调查。
研究设计与样本
- 回顾性队列研究,基于2010-2019年Medicare承运人索赔数据。
- 纳入94,829例EK手术(71,040例唯一患者),患者年龄≥65岁。
- 采用Kaplan-Meier法估计重复角膜移植概率,log-rank检验比较,Cox比例风险回归分析风险因素。
主要发现
- 94,829例EK中11,013例发生重复角膜移植。
- 重复角膜移植总体概率:6个月6.1%,1年7.6%,5年14.3%,8年16.9%。
- 既往移植失败者重复角膜移植概率1年10.2%,8年29.9%。
- Fuchs内皮营养不良(FED)者1年6.4%,8年11.4%;大泡性角膜病变和/或角膜水肿者1年8.6%,8年22%。
- 多变量分析中,黑人HR 1.29(95%CI 1.20-1.38),亚洲人HR 1.26(95%CI 1.10-1.45),青光眼诊断HR 1.53(95%CI 1.46-1.60),既往青光眼手术HR 1.26(95%CI 1.18-1.35),同期青光眼手术HR 1.31(95%CI 1.20-1.44)。
临床怎么用
- 对合并青光眼或需青光眼手术的EK患者,应加强术后监测和风险沟通。
- 关注种族差异及术者手术量对移植失败风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate long-term rates of repeated keratoplasty after endothelial keratoplasty (EK), and to explore risk factors associated with graft failure. DESIGN: Retrospective, cohort study. METHODS: Population-based using 2010-2019 Medicare carrier claims. STUDY POPULATION: Medicare beneficiaries aged ≥65 years who underwent endothelial keratoplasty (EK) procedures. Main outcome measures were 1) occurrence of repeated keratoplasty for the overall cohort as well as stratified by clinical indication, and 2), risk factors associated with repeated keratoplasty. The probability of undergoing repeated keratoplasty for different indications was estimated using the Kaplan-Meier method and compared using the log-rank test. A Cox proportional hazards regression model was constructed to determine patient and physician factors associated with the risk of repeated keratoplasty. RESULTS: A total of 94,829 Medicare EK procedures (N = 71,040 unique patients) were included in the analysis. Over the study period, 11,013 of 94,829 EK procedures were followed by repeated keratoplasty. The overall probability of receiving a repeated keratoplasty was 6.1% at 6 months, 7.6% at 1 year, 14.3% at 5 years and 16.9% at 8 years. The probability of repeated keratoplasty was highest for procedures performed for prior failed grafts: 10.2% at 1 year, 29.9% at 8 years. Whereas 6.4% and 11.4% of grafts performed for Fuchs' endothelial dystrophy (FED) required repeated keratoplasty at 1 and 8 years of follow-up, respectively. For bullous keratoplasty and/or corneal edema, 8.6% and 22% of grafts underwent repeated keratoplasty at 1 and 8 years, respectively. In a multivariate analysis, patient factors associated with increased risk of repeated keratoplasty were black (hazard ratio [HR]: 1.29; 95% confidence interval [CI]: 1.20-1.38) or Asians (HR: 1.26; 95% CI: 1.10-1.45) having a glaucoma diagnosis (HR: 1.53; 95% CI: 1.46-1.60), prior glaucoma surgery (HR: 1.26; 95% CI: 1.18-1.35), and concurrent glaucoma surgery (HR: 1.31; 95% CI: 1.20-1.44). Surgeons with higher EK volumes had a decreased risk of repeated keratoplasty. Physicians who graduated medical school >30 years previously had increased risk of repeated keratoplasty compared to those who graduated within 10 years (HR: 1.16; 95% CI: 1.10-1.23). CONCLUSIONS: Blacks or Asians, comorbid glaucoma, concurrent or prior glaucoma surgery, and lower volumes of surgery are associated with increased risk of repeated keratoplasty. Racial disparities identified in this study warrant further investigation.
引用
- Zafar S, Wang P, Woreta FA, et al. Risk Factors for Repeat Keratoplasty after Endothelial Keratoplasty in the Medicare Population. Am J Ophthalmol. 2020. PMID: 32791066. doi:10.1016/j.ajo.2020.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。